Shares of Cigna CI rose 0.3% in pre-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share decreased 18.56% year over year to $3.51, which missed the estimate of $3.68.
Revenue of $41,669,000,000 rose by 14.04% from the same period last year, which beat the estimate of $39,990,000,000.
Guidance
Cigna said it sees FY21 adjusted EPS of $20+ and sales of $165 billion+.
Details Of The Call
Date: Feb 04, 2021
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/5z4izut2
Recent Stock Performance
Company's 52-week high was at $230.90
Company's 52-week low was at $118.50
Price action over last quarter: Up 9.43%
Company Profile
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S., but its services extend internationally in over 30 countries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.